CITrials Partners With Roche Pharmaceuticals To Develop Novel Treatment For Schizophrenia

CITrials, an advanced medical research company, is now working with Roche Pharmaceuticals to develop a novel treatment for people suffering from schizophrenia. By collaborating with a pioneer in the health care industry, CITrials is committed to groundbreaking scientific and technological advances that have the potential to transform the lives of people suffering from schizophrenia.

As CITrials' pharmaceutical partner, Roche Pharmaceuticals will help identify new and better ways to prevent, detect, diagnose, control, and treat schizophrenia and its different forms. Moreover, this partnership complements CITrials' core values to provide a high standard of consumer care and to make a significant difference . . .